$NXTC SEC Filings

Filed On	Filing
20 Oct 2026	SCHEDULE 13G
01 Oct 2026	S-4/A
25 Sep 2026	425
25 Sep 2026	8-K: Other Events Petitioner NextCure, Inc. (“NextCure” or the “Company”), by and through its undersigned counsel, brings this petition pursuant to 8 Del. C. § 205, seeking to have this Court validate a potentially defective corporate act as follows:
03 Sep 2026	8-K: Entry into a Material Definitive Agreement
18 Aug 2026	S-4
14 Aug 2026	SCHEDULE 13G
14 Aug 2026	SCHEDULE 13G/A
14 Aug 2026	SCHEDULE 13G/A
13 Aug 2026	SCHEDULE 13G/A
12 Aug 2026	SCHEDULE 13G
12 Aug 2026	Form 4: Simcere Zaiming, Inc., Former 10% Owner and 5 others Sold 30,000 shares ($185K)
10 Aug 2026	425
06 Aug 2026	10-Q
06 Aug 2026	8-K: Results of Operations and Financial Condition
04 Aug 2026	425
03 Aug 2026	Form 4: ADAR1 Capital Management, Llc, 10% owner and 1 other Bought 292,850 shares ($1.44M) · Bought 36,303 shares ($179K)
29 Jul 2026	Form 4: ADAR1 Capital Management, Llc, 10% owner and 1 other Bought 7,798 shares ($39K) · Bought 6,400 shares ($31.7K) · Bought 3,410 shares ($17.1K)
29 Jul 2026	Form 3: ADAR1 Capital Management, Llc, 10% owner and 1 other Holds 375,658 shares of Common Stock
16 Jul 2026	425

Comments